Doctor profile · Federal record

Dr. Michael Rosen, M.D.

Internal Medicine Physician (CMS: Rheumatology) · Rheumatology Physician · West Chester, PA

  • NPI 1619931672
  • Accepts Medicare
  • MIPS 98.5 / 100 · 2023
  • 47 yrs in practice
  • Male
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
795 E Marshall St, Suite 101
West Chester, PA 193804400
(610) 692-4666
fax (610) 692-8261

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
September 11, 2025
Year of graduation
1979 — 47 yrs since
Specialty taxonomy
207R00000X — NUCC code
State license (1)
Pennsylvania #MD024177E
Medicaid
PA #0008586860001

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1619931672. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
51,528
Distinct HCPCS
10
Medicare allowed
$1,916,439
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 19,975 61 $42
J0897 Injection, denosumab, 1 mg 10,860 146 $23
J1602 Injection, golimumab, 1 mg, for intravenous use 7,399 14 $13
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,682 32 $32
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 1,900 15 $47
J9312 Injection, rituximab, 10 mg 1,590 13 $79
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 1,530 16 $42
99214 Established patient office or other outpatient visit, 30-39 minutes 656 327 $135
96413 Administration of chemotherapy into vein, 1 hour or less 503 142 $141
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 332 170 $79

In context: peer comparison

Among 13 peers in West Chester Internal Medicine Physician, average services per provider: 559. This provider delivers 92× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,604
Transactions
176
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 42 $900.60
Novartis Pharmaceuticals Corporation 26 $338.39
Abbvie INC. 20 $334.76
AstraZeneca Pharmaceuticals Lp 16 $330.94
Ucb, INC. 11 $284.87
E.R. Squibb & Sons, L.L.C. 15 $226.81
Janssen Biotech, INC. 8 $195.13
Pfizer INC. 15 $154.16
GlaxoSmithKline, LLC. 5 $127.39
Kiniksa Pharmaceuticals International, Plc 4 $110.17
Fresenius Kabi USA, LLC 5 $91.04
Mallinckrodt Hospital Products INC. 3 $81.07
Radius Health, INC. 2 $75.14
Organon LLC 3 $55.40
Janssen Scientific Affairs, LLC 1 $40.60

By nature of payment

Food and Beverage
$3,604

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,664
Patients
455
Total drug cost
$417,169
Drug Type Claims Patients Total cost
Prednisone Generic 292 101 $4,669
Methotrexate (Methotrexate Sodium) Brand 246 69 $11,972
Alendronate Sodium Generic 240 74 $3,408
Tramadol Hcl Generic 225 40 $1,681
Celecoxib Generic 123 41 $9,395
Hydroxychloroquine Sulfate Generic 96 27 $4,853
Allopurinol Generic 82 21 $1,114
Omeprazole Generic 70 24 $941
Pregabalin Generic 62 16 $3,622
Naproxen Generic 55 18 $1,203

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Rosen's medical specialty?
Dr. Michael Rosen practices Internal Medicine Physician in West Chester, PA.
Where does Dr. Michael Rosen practice?
Dr. Michael Rosen practices at 795 E Marshall St, West Chester, PA 193804400. Office phone: 6106924666.
What is Dr. Michael Rosen's NPI?
Dr. Michael Rosen's National Provider Identifier (NPI) is 1619931672, issued by NPPES.
Does Dr. Michael Rosen accept Medicare assignment?
Yes. Dr. Michael Rosen accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Rosen commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.